Vertex Newsroom

Vertex(VERX.US) 10% Shareholder Sells US$4.07 Million in Common Stock

$Vertex(VERX.US)$ 10% Shareholder ITEM SECOND IRR. TRUST FBO KYLE R. WESTPHAL u/a of JEFFREY R. WESTPHAL dated October 5, 2001 sold 72,000 shares of common stock on Jan 22, 23, 2025 at an average

Futu NewsJan 24 07:43

Vertex to Announce Fourth Quarter 2024 Financial Results on Thursday, February 27, 2025

GlobeNewswireJan 23 05:30

GF SEC: VERTEX JPM meeting update, focusing on the progress in the fields of domestic enterprise pain and kidney disease.

The success of Suzetrigine offers hope for the development of the Nav1.8 target, and based on its inherent mechanism advantages, it is expected to bring a new, safer, and more effective therapy for pain patients.

Zhitong FinanceJan 19 20:39

Goldman Sachs has launched a new investment guide for emerging Software in the USA: this year, head towards these five CNI Mid-Small Cap Index Software themes to "pan for gold."

The bank pointed out five CNI Mid-Small Cap.Index Software themed Stocks that are expected to bring better investment returns this year.

Zhitong FinanceJan 16 16:25

Vertex Recognized in Built In's Esteemed 2025 Best Places to Work Awards

GlobeNewswireJan 9 23:00

Here's Why You Should Add Vertex Stock to Your Portfolio Now

Zacks Jan 7 23:35

Vertex Shares Fall After Downgrade From Raymond James

MT NewswiresJan 4 03:40

Salesforce Is Raymond James' Top Software Stock for 2025 as Firm Tweaks Ratings

Seeking AlphaJan 4 00:55

Raymond James Downgrades Vertex(VERX.US) to Hold Rating

Futu NewsJan 3 18:33 · Ratings

Express News | Vertex Inc : Raymond James Cuts to Market Perform From Outperform

BreakingsJan 3 16:37

Vertex (NASDAQ:VERX) Might Have The Makings Of A Multi-Bagger

Simply Wall StJan 2 18:24

This Vertex Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Tuesday

BenzingaDec 31, 2024 22:22

Beyond The Numbers: 12 Analysts Discuss Vertex Stock

BenzingaDec 31, 2024 20:00

Vertex Price Target Announced at $62.00/Share by DA Davidson

Dow JonesDec 31, 2024 19:00 · Ratings

Vertex Initiated at Buy by DA Davidson

Dow JonesDec 31, 2024 19:00 · Ratings

D.A. Davidson Initiates Vertex(VERX.US) With Buy Rating, Announces Target Price $62

Futu NewsDec 31, 2024 07:31 · Ratings

Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13

BusinesswireDec 24, 2024 05:05

Vertex Gets Expanded FDA Approval for Cystic Fibrosis Treatment

WSJDec 21, 2024 05:00

Vertex Announces US FDA Approval of ALYFTREK, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

BusinesswireDec 21, 2024 04:46

Vertex Announces U.S. FDA Approval for TRIKAFTA (Elexacaftor/tezacaftor/ivacaftor and Ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants

BusinesswireDec 21, 2024 04:35